Mizoram to observe 'COVID-19 - No Tolerance Fortnight' from Oct 26

▴ Mizoram to observe 'COVID-19 - No Tolerance Fortnight' from Oct 26
In Mizoram, the state government has decided to observe 'COVID-19 - No Tolerance Fortnight' beginning from 26th October as a containment measure to flatten the curve of Covid-19 in the state.

In Mizoram, the state government has decided to observe 'COVID-19 - No Tolerance Fortnight' beginning from 26th October as a containment measure to flatten the curve of Covid-19 in the state.
 
The decision was taken yesterday in a meeting chaired by the Health & Family Welfare Minister Dr. R. Lalthangliana to assess the COVID-19 situation in the state.
 

Dr. R. Lalthangliana said that the state government has accorded zero tolerance policy to flouting any COVID-19 containment measures being implemented and enforced. He added that all Unlock Guidelines, all SOPs and all sections of the Mizoram Containment and Prevention of COVID-19 Ordinance, 2020 will be enforced very strictly.

 
The meeting expressed concern over the opening of some classes (Class X and XII) in schools and also the increased vehicular traffic in Aizawl city and suggested that these need to be reviewed in a more detailed manner.

Tags : #mizoram #covid19cases #drlalthangliana #healthandfamilywelfare #containmentmeasures

Related Stories

09 Nov

Full dose of Zydus Cadila's Covid vaccine at Rs 1,128

Zycov-D is the first DNA Plasmid vaccine

View
21 Aug

First needle less COVID vaccines for children and adult above 12 years got approval for EUA

Zydus Cadila’s ZyCov-D, Covid vaccine got Emergency Use Authorization for children and adults 12 years and above

View
26 Jun

Country soon to get world’s first DNA-plasmid vaccine by Zydus Cadilla: Chairman COVID-19 NTAGI

Zydus Cadila vaccine to be available by September

View
22 Jun

Zydus and Bayer announce continuity of their successful Joint Venture

Bayer Zydus Pharma has been a successful partnership combining Bayer’s scientific expertise and commercialization of novel products backed by Cadila Healthcare’s strong India presence.

View
19 Jun

European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

The approval confirms Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European Union.

View
06 Jan

Top Ten Pharma Companies of India : January 2021

Top ten pharma stocks January 2021

View
30 Dec

Zydus announces the approval of Saroglitazar Mg for the treatment of Non-Alcoholic fatty Liver disease in India

About 25 to 30% of Indian population suffers from NALD

View
12 Dec

India readies for 600 million COVID vaccine jabs; to use standard cold storage - top government expert

India will deploy its vast election machinery to deliver 600 million doses of COVID-19 vaccines to the most vulnerable people in the next six to eight months through conventional cold chain systems.

View
08 Dec

India in the forefront of developing COVID-19 vaccines: Dr Harsh Vardhan

India is among the top ten countries in the world with respect to the number of patents filed.

View
07 Dec

Pfizer seeks emergency use authorization for its COVID-19 vaccine in India

India to soon have the Covid-19 vaccine from Serum and Pfizer

View

-Advertisements-




Trending Now

Teenagers Are Losing Friends While Chasing Perfection: Here’s WhyMarch 13, 2025
Your Desk Job is Destroying Your Mind: Here’s How to Fight BackMarch 13, 2025
Wow! Momo Disrupts FMCG Cup Noodles Market with 'Desi-Asian Flavours' – A First in IndiaMarch 13, 2025
How India’s Kidney Health Crisis is Growing UnnoticedMarch 13, 2025
Stuck Between the Snooze Button and the Hustle: Entrepreneurs Struggle to Get Quality SleepMarch 13, 2025
Can Coffee Keep You Steady on Your Feet? New Study Reveals the TruthMarch 13, 2025
NephroPlus Sets Guinness World Record & India Book of Records Title for Largest Kidney Health Screening DriveMarch 12, 2025
India Choosing to Eat Healthy; Order Volumes Up by 60% for Nutritional ProductsMarch 12, 2025
Amrita students win first prize at DecodeX 2025 hackathonMarch 12, 2025
Why Millions Are Losing Their Sight to Glaucoma And How You Can Prevent ItMarch 12, 2025
Çelebi India Ranks 3rd Worldwide in Ground Handling Performance for Turkish CargoMarch 12, 2025
Advancing Road Safety Through Clear Vision: VARS 4.0 Sets Bold AgendaMarch 12, 2025
The Deadly Cost of the “Perfect Body”: When Diet Trends Turn FatalMarch 12, 2025
Lighthouse Canton’s LC GenInnov Global Innovation Fund Secures Investment from Kotak Mahindra Asset ManagementMarch 11, 2025
TTK Prestige Revolutionizes Cooking with Innovative AirFlip Two-in-One Air Fryer and GrillMarch 11, 2025
Rewriting Immunology: The Discovery That Could Replace Traditional AntibioticsMarch 11, 2025
Is Your Cooking Oil Poisoning You? The Truth About Seed OilsMarch 11, 2025
Think Before You Bite: How Fatty Foods Can Trigger Brain Damage in Just 3 DaysMarch 11, 2025
Ditch the Pills: The Secret to Beating Insomnia is in Your WorkoutMarch 11, 2025
The University of Tasmania invites applications for Master of Public HealthMarch 11, 2025